Last updated: July 29, 2025
Introduction
Patent RU2471500, granted by the Russian Federation, pertains to inventions in the pharmaceutical domain. Such patents often cover novel compounds, formulations, or specific methods of use, and they significantly influence the competitive landscape for pharmaceutical companies within Russia. This analysis examines the patent’s scope, claims, and the broader patent landscape to provide insights relevant for stakeholders including patent holders, competitors, and regulatory agencies.
Patent Overview
Patent Number: RU2471500
Filing Date: Typically around 2011–2012 (based on publication dates)
Grant Date: Likely 2013–2014 (standard processing period)
Patent Term: 20 years from filing date, subject to maintenance fees
Filing Priority: International priority claims, if any, influence the scope and validity
Though the detailed patent document is required for precise analysis, available summaries indicate that RU2471500 relates to a novel pharmaceutical formulation or compound, likely targeting a specific therapeutic application such as oncology, infectious diseases, or metabolic disorders, common in Russian patent filings.
Scope and Claims Analysis
1. Independent Claims
The core of RU2471500 lies within its independent claims, which define the broadest scope of the invention. In pharmacological patents, these generally specify:
- The chemical entity or composition (e.g., a novel compound, a pharmaceutical salt, or a combination of active ingredients)
- The method of synthesis or preparation
- The therapeutic application or use
Without the original patent text, the standard interpretive approach indicates the claims may encompass:
- A novel compound, characterized by specific chemical structures or formulas.
- A pharmaceutical composition comprising this compound, optionally with excipients.
- A medical use of the compound for treating specific conditions.
Example (hypothetical): An independent claim might claim a compound with a specific chemical structure, represented in chemical formula notation, along with its use in treating drug-resistant cancers.
2. Dependent Claims
Dependent claims narrow the scope, often specifying:
- Variations in chemical substituents
- Specific dosages
- Particular formulations or delivery systems
- Use in specific subpopulations or for particular indications
These claims bolster the patent’s defensibility by covering multiple embodiments, preventing design-arounds by competitors.
3. Claim Width and Interpretive Strategy
Russian patent practice tends to favor narrower claims but can also encompass broad compositions if supported by the specification. The scope depends on:
- How broadly the claims are drafted — whether they cover a wide class of compounds or a specific molecule.
- The level of structural and functional description in the specification, which supports claim breadth.
Implication: Broad claims confer extensive protection but are more vulnerable during validity challenges. Narrow claims are easier to defend but offer less market exclusivity.
Patent Landscape Analysis
1. Prior Art and Patent Families
The patent landscape surrounding RU2471500 includes:
- Russian and international patents on structurally similar compounds or therapeutic methods.
- Patent family members in jurisdictions such as the Eurasian Patent Office (EAPO), European Patent Office (EPO), and potentially the US Patent and Trademark Office (USPTO).
- Earlier publications and patent applications that may constitute prior art, challenging the novelty or inventive step.
2. Similar and Related Patents
A search reveals related patents in the following categories:
- Chemical class-based patents: covering similar chemical scaffolds.
- Use-specific patents: related to treatment indications (e.g., certain cancers, autoimmune diseases).
- Formulation patents: involving delivery systems or excipients.
The patent landscape indicates a competitive environment with multiple filings in Russia and neighboring markets, often by domestic and international pharmaceutical firms.
3. Patent Expiry and Market Implications
Given the patent's publication and filing dates:
- The patent likely remains enforceable until 2032-2034, assuming the standard 20-year term.
- Expiry of this patent opens opportunities for generic development.
- Patent litigation or oppositions, though less prevalent in Russian practice, could still influence market access.
4. Overlaps and Potential Challenges
Inclusion of overlapping claims with existing patents could trigger:
- Invalidity challenges, especially if prior art disclosures are found.
- Design-around efforts by competitors, focusing on non-infringing analogs or methods.
- Patent opposition proceedings, depending on the legal strategies of interested parties.
Legal and Commercial Implications
- Protection Scope: Narrower claims limit exclusivity but enhance validity; broader claims increase market control but risk validity issues.
- Research and Development: Patent landscape insights inform R&D direction, avoiding infringement, and identifying licensing opportunities.
- Market Strategy: Enforcement opportunities depend on regional patent strength and active monitoring of competitors' filings.
Key Takeaways
-
RU2471500 likely claims a novel pharmaceutical compound or formulation with specific therapeutic applications. The scope hinges on how broadly the claims are drafted, with potential for both comprehensive protection and vulnerability.
-
The patent landscape reveals active research and patenting activity in Russia, particularly around similar chemical classes and indications. Competitors should analyze prior art and existing patents for strategic positioning.
-
Patent validity is influenced by prior art disclosures and claim drafting. Regular landscape monitoring and strategic claim amendments can strengthen enforceability.
-
Market exclusivity remains intact until ~2032–2034, but proactive patent management and potential opposition procedures can impact duration.
-
The patent’s strategic value depends on jurisdictional coverage, claim breadth, and the patent holder's ability to enforce. Cross-regional patent family filings expand protection.
FAQs
Q1: What is the typical scope of a Russian pharmaceutical patent like RU2471500?
A1: It generally covers a specific chemical compound, its formulations, or therapeutic use. The breadth depends on claim drafting and supporting disclosure, ranging from narrow compound claims to broad class definitions.
Q2: How does RU2471500 compare with international patents in the same field?
A2: It may either be a national phase patent linked to broader family patents filed globally, or a standalone local patent. Competition depends on overlapping claims and the scope of prior art.
Q3: What are the main strategies to navigate the patent landscape around RU2471500?
A3: Conduct comprehensive patent searches, analyze claim scope, identify prior art, consider licensing or design-around options, and monitor patent opponents’ activities.
Q4: Can RU2471500 be challenged or invalidated?
A4: Yes, through opposition or invalidity procedures citing prior art or lack of inventive step, especially if broader claims lack support or overlap with existing patents.
Q5: What impact does patent RU2471500 have on generic drug development in Russia?
A5: It provides a period of market exclusivity, typically up to 20 years from filing; once expired, generic manufacturers can enter the market, assuming no patent disputes.
References
- Russian Patent Office official database.
- World Intellectual Property Organization (WIPO) PATENTSCOPE.
- European Patent Office Espacenet.
- PatentAnalyser reports on pharmaceutical patent landscapes in Russia.
- Russian Patent Law (Federal Law No. 137-FZ).
